Vivos Therapeutics (NASDAQ: VVOS) insider entity buys 5.5M derivatives
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vivos Therapeutics, Inc. large shareholder Michael C. Skaff, through V-Co Investors 4 LLC, recorded purchases totaling 5,498,660 derivative securities tied to common stock on June 30, 2026. The entity acquired 2,749,330 Common Stock Purchase Warrants and blocks of Series A Convertible Preferred Stock (1,890,164 and 859,166 shares) at $0.582 per unit.
The warrants are exercisable for common shares at $0.456 per share until June 30, 2031. The Series A Convertible Preferred Stock is convertible into common stock at any time, subject to a beneficial ownership limitation and has no expiration date. A footnote states that V-Co Investors 4 LLC converted a $1,000,000 bridge promissory note into Series A Convertible Preferred Stock, and Skaff and SP Manager LLC disclaim beneficial ownership beyond their pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 5,498,660 shares ($3,200,220)
Net Buy
3 txns
Insider
Skaff Michael C
Role
10% Owner
Bought
5,498,660 shs ($3.20M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Series A Convertible Preferred Stock | 859,166 | $0.582 | $500K |
| Purchase | Series A Convertible Preferred Stock | 1,890,164 | $0.582 | $1.10M |
| Purchase | Common Stock Purchase Warrant | 2,749,330 | $0.582 | $1.60M |
Holdings After Transaction:
Series A Convertible Preferred Stock — 859,166 shares (Indirect, By V-Co Investors 4 LLC);
Common Stock Purchase Warrant — 2,749,330 shares (Indirect, By V-Co Investors 4 LLC)
Footnotes (1)
- The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date. Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. On June 30, 2026, V-Co Investors 4 LLC converted a bridge promissory note in the amount of $1,000,000 entered into between the reporting person and the Issuer into shares of the Issuer's Series A Convertible Preferred Stock, based on $0.456 per share plus $0.125 per share in accordance with the Nasdaq minimum price rules.
Key Figures
Total derivative shares purchased: 5,498,660 shares
Warrants acquired: 2,749,330 warrants
Series A Preferred acquired (block 1): 1,890,164 shares
+5 more
8 metrics
Total derivative shares purchased
5,498,660 shares
Net derivative securities bought on June 30, 2026 across three transactions
Warrants acquired
2,749,330 warrants
Common Stock Purchase Warrants tied to 2,749,330 underlying common shares
Series A Preferred acquired (block 1)
1,890,164 shares
Series A Convertible Preferred Stock with 1,890,164 underlying common shares
Series A Preferred acquired (block 2)
859,166 shares
Additional Series A Convertible Preferred Stock with 859,166 underlying common shares
Purchase price per unit
$0.582 per share
Price reported for warrants and Series A Convertible Preferred Stock purchases
Exercise / conversion price
$0.456 per share
Exercise price for warrants and conversion price component for preferred stock
Bridge promissory note converted
$1,000,000
Principal amount converted into Series A Convertible Preferred Stock on June 30, 2026
Warrant expiration date
June 30, 2031
Expiry of Common Stock Purchase Warrants acquired by V-Co Investors 4 LLC
Key Terms
Common Stock Purchase Warrant, Series A Convertible Preferred Stock, beneficial ownership limitation, bridge promissory note, +1 more
5 terms
Common Stock Purchase Warrant financial
"Security title is Common Stock Purchase Warrant with 2,749,330 underlying shares"
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
Series A Convertible Preferred Stock financial
"Transactions involve Series A Convertible Preferred Stock tied to common shares"
Series A convertible preferred stock is a class of shares sold in an early funding round that gives investors a mix of protection and upside: it pays a priority claim over common shares if the company is sold or closes, but can be converted into ordinary shares to share in future growth. Think of it like a hybrid between a safer stake and a ticket to ownership; it matters to investors because it affects who controls the company, how future gains are split, and how much their investment is protected from downside.
beneficial ownership limitation regulatory
"Convertible preferred stock is convertible subject to a beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
bridge promissory note financial
"V-Co Investors 4 LLC converted a bridge promissory note in the amount of $1,000,000"
Nasdaq minimum price rules regulatory
"Conversion based on $0.456 per share plus $0.125 per share under Nasdaq minimum price rules"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Michael C. Skaff report for VVOS on June 30, 2026?
Michael C. Skaff, via V-Co Investors 4 LLC, reported buying 5,498,660 derivative securities tied to Vivos Therapeutics common stock on June 30, 2026. These include warrants and Series A Convertible Preferred Stock acquired at $0.582 per unit.
What are the key terms of the VVOS warrants and Series A Convertible Preferred Stock?
The warrants are exercisable for common stock at $0.456 per share and expire on June 30, 2031. The Series A Convertible Preferred Stock is convertible into common shares at any time, subject to a beneficial ownership limitation, and has no expiration date.
How does the $1,000,000 bridge promissory note relate to these VVOS insider holdings?
A footnote states V-Co Investors 4 LLC converted a $1,000,000 bridge promissory note into shares of Series A Convertible Preferred Stock. The conversion was based on $0.456 per share plus $0.125 per share under Nasdaq minimum price rules.
Does Michael C. Skaff directly own the reported VVOS securities?
The securities are held indirectly through V-Co Investors 4 LLC, managed by SP Manager LLC where Skaff is Managing Director. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest.
What is the beneficial ownership limitation mentioned for VVOS preferred stock?
The Series A Convertible Preferred Stock is convertible into common stock only subject to a beneficial ownership limitation. This means conversions cannot exceed a specified ownership threshold, helping prevent the holder from surpassing an agreed beneficial ownership percentage.